Page last updated: 2024-11-05

dithiazanine iodide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Cross-References

ID SourceID
PubMed CID5702697
CHEMBL ID421701
CHEBI ID228275
MeSH IDM0006611

Synonyms (86)

Synonym
CHEMBL421701
unii-8oec3ra07x
smr000059184
MLS000069807 ,
3-ethyl-2-[(1e,3e,5z)-5-(3-ethyl-1,3-benzothiazol-2(3h)-ylidene)penta-1,3-dien-1-yl]-1,3-benzothiazol-3-ium iodide
dqoci
dilombrin
3,2'-thiadicarbocyanine iodide
wln: t56 bnysj b2 cu2u2u1- ct56 bk dsj b2 &i
dilombrine
compound 01748
eastman 7663
anguifugan
3-ethyl-2-[5-(3-ethyl-2-benzothiazolinylidene)-1,3-pentadienyl]benzothiazolium iodide
nsc-26010
dithiazine
[2-bis(3-ethylbenzothiazolyl)]pentamethine cyanine iodide
3,3'-diethyldithiacarbodicyanine iodide
omni-passin
telmid
telmide
dithiazanin iodide
partel
3,3-diethylthiadicarbocyanine iodide
netocyd
nk 136
vercidon
anelmid
diethylthiadicarbocyanine iodide
dejo
l-01748
telmicid
benzothiazolium,3-pentadienyl]-, iodide
nsc26010
dizan
3,3'-diethylpentamethinethiacyanine iodide
benzothiazolium, 3-ethyl-2-(5-(3-ethyl-2-benzothiazolinylidene)-1,3-pentadienyl)-, iodide
deselmine
3-ethyl-2-(5-(3-ethyl-2-(3h)-benzothiazolylidene)-1,3-pentadienyl)benzothiazolium iodide
ai3-50132
3,3'-diethyl-2,2'-thiadicarbocyanine iodide
(2-bis(3-ethylbenzothiazolyl))pentamethine cyanine iodide
ossiurene (amsa, italy)
benzothiazolium, 3-ethyl-2-(5-(3-ethyl-2(3h)-benzothiazolylidene)-1,3-pentadienyl)-, iodide
3-ethyl-2-(5-(3-ethyl-2-benzothiazolinylidene)-1,3-pentadienyl)benzothiazolium iodide
dithiazinine
nectocyd
einecs 208-186-7
hsdb 6390
nsc-221154
nsc221154
3,3'-diethylthiadicarbocyanine iodide, dye content 98 %
c5-thiacyanine
CHEBI:228275 ,
dithiazanini iodidum
3-ethyl-2-[5-(3-ethyl-1,3-benzothiazol-2(3h)-ylidene)penta-1,3-dien-1-yl]-1,3-benzothiazol-3-ium iodide
thiadicarbocyanine (c5) dye
ioduro de ditiazanina
iodure de dithiazanine
C18391
dtxcid502955
dtdci
3-ethyl-2-[5-(3-ethyl-2(3h)-benzothiazolylidene)-1,3-pentadienyl]benzothiazolium iodide
AKOS025116954
OPERA_ID_673
VU0254060-4
169736-34-9
iodide, dithiazanine
3-ethyl-2-[(1e,3e)-5-[(2e)-3-ethyl-2,3-dihydro-1,3-benzothiazol-2-ylidene]penta-1,3-dien-1-yl]-1,3-benzothiazol-3-ium iodide
AS-75817
3-ethyl-2-(5-(3-ethyl-1,3-benzothiazol-2(3h)-ylidene)penta-1,3-dien-1-yl)-1,3-benzothiazol-3-ium iodide
3-ethyl-2-(5-(3-ethylbenzothiazol-2(3h)-ylidene)penta-1,3-dienyl)benzothiazolium iodide
di-s-c2(5)
dithiazanine iodide (usp:inn)
dizan tablets
dizan powder
dtdc
dithiazanine (base)
3-ethyl-2-(5-(3-ethyl-2-benzothiazolylidene)-1,3-pentadienyl)benzothiazolium iodide
dithiazanini iodidum (inn-latin)
ioduro de ditiazanina (inn-spanish)
dithiazanine iodide (mart.)
dithiazine (dye)
dithiazanine (cation)
iodure de dithiazanine (inn-french)
3-ethyl-2-(5-(3-ethyl-2-(3h)-benzothiazolylidene)-1,3-pentadienyl) benzothiazolium iodide
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
fluorochromeA fluorescent dye used to stain biological specimens.
anthelminthic drugSubstance intended to kill parasitic worms (helminths).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
organic iodide salt
benzothiazoles
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (49)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASEHomo sapiens (human)Potency25.11890.003245.467312,589.2998AID2517
Chain A, TYROSYL-DNA PHOSPHODIESTERASEHomo sapiens (human)Potency19.95260.004023.8416100.0000AID485290
Chain A, Beta-lactamaseEscherichia coli K-12Potency61.19360.044717.8581100.0000AID485294; AID485341
Chain A, Putative fructose-1,6-bisphosphate aldolaseGiardia intestinalisPotency15.81140.140911.194039.8107AID2451
Chain A, 2-oxoglutarate OxygenaseHomo sapiens (human)Potency22.38720.177814.390939.8107AID2147
Chain A, ATP-DEPENDENT DNA HELICASE Q1Homo sapiens (human)Potency35.48130.125919.1169125.8920AID2549
Chain A, Ferritin light chainEquus caballus (horse)Potency19.95265.623417.292931.6228AID485281
Chain A, CruzipainTrypanosoma cruziPotency35.71680.002014.677939.8107AID1476; AID1478
LuciferasePhotinus pyralis (common eastern firefly)Potency15.10140.007215.758889.3584AID588342
chaperonin-containing TCP-1 beta subunit homologHomo sapiens (human)Potency31.62283.981127.764939.8107AID504842
phosphopantetheinyl transferaseBacillus subtilisPotency22.38720.141337.9142100.0000AID1490
ATAD5 protein, partialHomo sapiens (human)Potency29.09290.004110.890331.5287AID504467
Microtubule-associated protein tauHomo sapiens (human)Potency10.88200.180013.557439.8107AID1460; AID1468
thioredoxin glutathione reductaseSchistosoma mansoniPotency50.11870.100022.9075100.0000AID485364
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency25.11890.011212.4002100.0000AID1030
luciferasePhoturis pensylvanica (Pennsylania firefly)Potency10.00000.891310.432820.5750AID1379
bromodomain adjacent to zinc finger domain 2BHomo sapiens (human)Potency11.22020.707936.904389.1251AID504333
alpha-galactosidaseHomo sapiens (human)Potency35.48134.466818.391635.4813AID1467
pyruvate kinaseLeishmania mexicana mexicanaPotency22.38720.398113.744731.6228AID1721; AID1722
euchromatic histone-lysine N-methyltransferase 2Homo sapiens (human)Potency28.18380.035520.977089.1251AID504332
serine-protein kinase ATM isoform aHomo sapiens (human)Potency31.62280.707925.111941.2351AID485349
Bloom syndrome protein isoform 1Homo sapiens (human)Potency31.62280.540617.639296.1227AID2528
lysosomal alpha-glucosidase preproproteinHomo sapiens (human)Potency28.18380.036619.637650.1187AID2100
NPC intracellular cholesterol transporter 1 precursorHomo sapiens (human)Potency0.28180.01262.451825.0177AID485313
polyunsaturated fatty acid lipoxygenase ALOX12Homo sapiens (human)Potency31.62281.000012.232631.6228AID1452
thyroid hormone receptor beta isoform aHomo sapiens (human)Potency35.48130.010039.53711,122.0200AID1479
huntingtin isoform 2Homo sapiens (human)Potency12.58930.000618.41981,122.0200AID1688
pyruvate kinase PKM isoform aHomo sapiens (human)Potency25.11890.04017.459031.6228AID1631; AID1634
DNA polymerase betaHomo sapiens (human)Potency15.84890.022421.010289.1251AID485314
ubiquitin carboxyl-terminal hydrolase 2 isoform aHomo sapiens (human)Potency22.38720.65619.452025.1189AID463254
ras-related protein Rab-9AHomo sapiens (human)Potency0.31620.00022.621531.4954AID485297
histone-lysine N-methyltransferase 2A isoform 2 precursorHomo sapiens (human)Potency19.95260.010323.856763.0957AID2662
nuclear receptor ROR-gamma isoform 1Mus musculus (house mouse)Potency7.87580.00798.23321,122.0200AID2546; AID2551
survival motor neuron protein isoform dHomo sapiens (human)Potency1.00000.125912.234435.4813AID1458
muscleblind-like protein 1 isoform 1Homo sapiens (human)Potency14.12540.00419.962528.1838AID2675
lamin isoform A-delta10Homo sapiens (human)Potency4.46680.891312.067628.1838AID1487
neuropeptide S receptor isoform AHomo sapiens (human)Potency7.94330.015812.3113615.5000AID1461
Endothelin receptor type BRattus norvegicus (Norway rat)Potency22.38720.562315.160931.6228AID1721
Endothelin-1 receptorRattus norvegicus (Norway rat)Potency22.38720.562315.160931.6228AID1721
ATP-dependent phosphofructokinaseTrypanosoma brucei brucei TREU927Potency26.85450.060110.745337.9330AID485367
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
XBP1Homo sapiens (human)IC50 (µMol)2.40000.16005.404910.0000AID504313
catenin beta-1 isoform 1Homo sapiens (human)IC50 (µMol)3.73003.73003.79003.8500AID1665
DNA damage-inducible transcript 3 proteinMus musculus (house mouse)IC50 (µMol)0.87000.16003.995910.0000AID504322
NACHT, LRR and PYD domains-containing protein 1 isoform 1Homo sapiens (human)IC50 (µMol)19.500012.900016.200019.5000AID488860
caspase-1 isoform alpha precursorHomo sapiens (human)IC50 (µMol)100.000015.900015.900015.9000AID488863
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
RGS7, partialHomo sapiens (human)EC50 (µMol)30.00000.14002.13004.7800AID1871
regulator of G-protein signaling 4Homo sapiens (human)EC50 (µMol)3.41000.13503.350610.0690AID1872
regulator of G-protein signaling 19Homo sapiens (human)EC50 (µMol)30.00000.11503.175614.1300AID1884
regulator of G-protein signaling 16Homo sapiens (human)EC50 (µMol)6.67000.05303.625816.0000AID1888
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (16)

Assay IDTitleYearJournalArticle
AID588459High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, Validation compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588459High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, Validation compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588459High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, Validation compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588460High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, Validation Compound Set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588460High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, Validation Compound Set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588460High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, Validation Compound Set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID588461High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, Validation compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588461High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, Validation compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588461High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, Validation compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID212558Taq polymerase inhibition at 20 mM concentration2001Bioorganic & medicinal chemistry letters, Sep-17, Volume: 11, Issue:18
G-quadruplex DNA binding by a series of carbocyanine dyes.
AID212549G4'-DNA binding-dependent Taq polymerase pausing is the ratio of pause/full bands at 20 uM carbocyanine concentration relative to control; expressed as Normalized ratio of G4'-DNA stop product; Not determined due to strong Taq polymerase inhibition2001Bioorganic & medicinal chemistry letters, Sep-17, Volume: 11, Issue:18
G-quadruplex DNA binding by a series of carbocyanine dyes.
AID375602Inhibition of His-tagged human recombinant 2N4R tau protein aggregation assessed as inhibition octadecyl sulphate-induced fibrillation by filter trap assay2009Journal of medicinal chemistry, Jun-11, Volume: 52, Issue:11
Structure-activity relationship of cyanine tau aggregation inhibitors.
AID212762Inhibition of human telomerase activity in S100 HeLa cell extract at 50 mM carbocyanine concentration.2001Bioorganic & medicinal chemistry letters, Sep-17, Volume: 11, Issue:18
G-quadruplex DNA binding by a series of carbocyanine dyes.
AID1224864HCS microscopy assay (F508del-CFTR)2016PloS one, , Volume: 11, Issue:10
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (42.86)29.6817
2010's4 (57.14)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]